Science & Medicine

S17 Ep48: FDA Approval Insights: Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma: With Alex Herrera, MD

Jul 9, 202613:56Science & Medicine

Alex Herrera, MD, discusses the FDA approval of nivolumab plus AVD for untreated classical Hodgkin lymphoma.

About This Episode

S17 Ep48: FDA Approval Insights: Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma: With Alex Herrera, MD is an episode from OncLive® On Air by Audioboom. Alex Herrera, MD, discusses the FDA approval of nivolumab plus AVD for untr...

Podcast

This episode belongs to OncLive® On Air.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 9, 2026, 13:56 long, audio available.

S17 Ep48: FDA Approval Insights: Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma: With Alex Herrera, MD

About This Episode

Related Episodes